EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Important Role of Phosphatidylserine, ADAM17, TNF‐Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity

Chandra Agung Purnama iD, Anna Meiliana iD, Melisa Intan Barliana iD, Keri Lestari iD, Andi Wijaya iD

Journal of Obesity · 2024-01 · 2024 (1)

DOI: 10.1155/2024/1424404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obesity, online erschienen am 20.03.2024. Verfasst von Chandra Agung Purnama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Ir. Soekarno Km 21, Jatinangor 45363, Indonesia. Hauptthemen laut MEDLINE: Phosphatidylserines, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prodia Clinical Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is expected to hinder efferocytosis due to ADAM17‐mediated cleavage of the MER tyrosine kinase receptor, producing soluble MER (sMER) that disrupts MERTK binding to cell death markers. However, the intracellular efferocytosis pathway in central obesity remains elusive, particularly the role of low‐grade chronic inflammation in its initiation and identification of binding signals that disrupt efferocytosis.

Objective

We investigate the efferocytosis signaling pathway in men with central obesity and its relationship with inflammation, cell death, and related processes.

Methods

A cross‐sectional study was conducted, and clinical data and blood samples were collected from 56 men with central obesity (obese group) and 29 nonobese individuals (control group). Clinical evaluations and predefined biochemical screening tests were performed. The efferocytosis signaling pathway was investigated by measuring phosphatidylserine (PS), ADAM17, TNF‐alpha (TNF‐ α ), and sMER.

Results

Metabolic syndrome was detected in more than half of the participants in the obese group according to the predefined tests. Mean levels of PS, TNF‐ α , and sMER were higher in the obese group but not significantly different from those of the control group. Further analysis based on waist circumference (WC) ranges in the obese group revealed a significant increase in PS and sMER levels between the control group and the obese group with WC greater than 120 cm. ADAM17 levels were significantly higher in the obese group than in the control group. PS was positively correlated with WC and ADAM17. ADAM17 was positively correlated with TNF‐ α and sMER, indicating impaired efferocytosis.

Conclusions

Central obesity appeared to cause a disturbance in efferocytosis that began with cell damage and death, along with an enlargement of the WC and an ongoing inflammatory response. Efferocytosis was disrupted by proinflammatory cytokine regulators, which induced the production of sMER and interfered with the efferocytosis process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhosphatidylserinesTumor Necrosis Factor-alphaHumansMaleADAM17 ProteinCross-Sectional StudiesEfferocytosisInflammationObesity, AbdominalPhagocytosisc-Mer Tyrosine Kinase

Substanzen

ADAM17 ProteinPhosphatidylserinesTumor Necrosis Factor-alphaADAM17 protein, humanMERTK protein, humanc-Mer Tyrosine KinaseTNF protein, human

Autor:innen und Institutionen

  • Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Ir. Soekarno Km 21, Jatinangor 45363, Indonesia.
  • Prodia Clinical Laboratory, Jl. Kramat Raya 150, Jakarta 10430, Indonesia.
  • Prodia Education and Research Institute, Jl. Kramat Raya 150, Jakarta 10430, Indonesia.
  • Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Ir. Soekarno Km 21, Jatinangor 45363, Indonesia.
  • Center of Excellence of Pharmaceutical Care Innovation, Universitas Padjadjaran, Jl. Ir. Soekarno Km 21, Jatinangor 45363, Indonesia.

ORCID-Profile: Chandra Agung Purnama, Anna Meiliana, Melisa Intan Barliana, Keri Lestari, Andi Wijaya

Förderung

  • Prodia Clinical Laboratory

Zitieren

APA

Purnama, C. A., Meiliana, A., Barliana, M. I., Lestari, K., & Wijaya, A. (2024). The Important Role of Phosphatidylserine, ADAM17, TNF‐Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity. Journal of Obesity, 2024(1). https://doi.org/10.1155/2024/1424404

Vancouver

Purnama CA, Meiliana A, Barliana MI, Lestari K, Wijaya A. The Important Role of Phosphatidylserine, ADAM17, TNF‐Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity. Journal of Obesity. 2024;2024(1). doi:10.1155/2024/1424404

BibTeX
@article{Purnama2024,
  author = {Purnama, Chandra Agung and Meiliana, Anna and Barliana, Melisa Intan and Lestari, Keri and Wijaya, Andi},
  title = {The Important Role of Phosphatidylserine, ADAM17, TNF‐Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity},
  journal = {Journal of Obesity},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/1424404}
}
Kostenlos starten →